Ravi Jain MD, PhD
With artificial intelligence (AI), the challenge was which applications should be introduced first to get all the stakeholders (health system administrators, patients, clinicians and radiologists) interested in the AI culture and maintain their enthusiastic support.
We found three FDA-cleared AI solutions available in the marketplace that aligned with three clinical situations we wanted to improve. These included long acquisition time for PET/CT, long acquisition times for MRI scans, and long wait times for the radiologist’s report on critical CT findings.
Outcomes and Limitations
AI for flagging the emergency department cases for ICH, PE, and LVO was introduced. 3 months of validation of the AI software took place, with false-negative rate as the primary method of validation. No false-negative cases were found during the validation phase. A very small subdural ICH identified by the AI software may have been missed by the radiologist. The accuracy of the algorithms for PE and LVO is extremely high, and AI excels in identifying PE in the small vessels.